Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-26-034417
Filing Date
2026-03-26
Accepted
2026-03-26 09:29:33
Documents
2
Period of Report
2026-03-26

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea0282971-6k_canfite.htm 6-K 9561
2 PRESS RELEASE DATED MARCH 26, 2026 ea028297101ex99-1.htm EX-99.1 111601
  Complete submission text file 0001213900-26-034417.txt   122182
Mailing Address 26 BEN GURION STREET RAMAT GAN L3 5257346
Business Address 26 BEN GURION STREET RAMAT GAN L3 5257346 972 39241114
Can-Fite BioPharma Ltd. (Filer) CIK: 0001536196 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36203 | Film No.: 26794685
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)